MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing

BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc.® (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for age-related diseases, autoimmune and inflammatory conditions, announced today that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for ... Read More

2024 Reputation Strategy & Brand Resilience Summit: San Diego, CA, United States – April 2-3, 2024 – Join 120+ PR/Marketing & Communications Professionals for the Industry’s ONLY ‘TED-Style’ Summit – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “2024 Reputation Strategy & Brand Resilience Summit” conference has been added to ResearchAndMarkets.com’s offering. Whether you’re a small local company dealing with negative online reviews or a large movie studio or company hiring a crisis management firm to deal with increased scrutiny from the media, online, and the ... Read More

Organigram Reports First Quarter Fiscal 2024 Results

TORONTO–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the first quarter ended December 31, 2023 (“Q1 Fiscal 2024”). “We certainly kicked off fiscal 2024 with a bang”, said Beena Goldenberg, Chief Executive Officer. “By closing the ... Read More